Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 25.06%3.07B | 40.46%2.46B | 35.46%659.75M | 56.41%614.34M | 34.68%571.27M | 37.36%610.83M | -3.75%1.75B | -9.36%487.03M | -14.53%392.78M | -5.18%424.16M |
| Cost of revenue | 22.93%1.5B | 26.31%1.22B | 20.08%319.53M | 34.05%322.52M | 20.26%294.42M | 32.24%284.31M | 33.24%966.52M | 17.15%266.1M | 37.16%240.61M | 45.52%244.81M |
| Gross profit | 27.16%1.57B | 57.95%1.24B | 54.00%340.22M | 91.76%291.82M | 54.36%276.85M | 42.15%326.52M | -28.34%782.15M | -28.77%220.93M | -46.45%152.18M | -35.74%179.35M |
| Operating expense | 13.38%1.83B | 30.25%1.62B | 45.39%460.18M | 32.14%408.52M | 19.03%374.79M | 24.09%372.41M | 29.97%1.24B | 17.19%316.51M | 28.85%309.16M | 32.08%314.89M |
| Operating profit | 31.37%-261.14M | 17.01%-380.5M | -25.49%-119.96M | 25.65%-116.71M | 27.74%-97.94M | 34.82%-45.89M | -435.12%-458.51M | -338.41%-95.59M | -455.02%-156.98M | -432.99%-135.54M |
| Net non-operating interest income (expenses) | -56.58%-357K | 41.09%-228K | -80.56%-130K | -6.19%-103K | 126.73%27K | 81.20%-22K | 91.57%-387K | 50.00%-72K | 97.58%-97K | 48.73%-101K |
| Non-operating interest income | 522.00%311K | 284.62%50K | 157.14%18K | --2K | 400.00%30K | --0 | 116.67%13K | 75.00%7K | --0 | 200.00%6K |
| Non-operating interest expense | 140.29%668K | -30.50%278K | 87.34%148K | 8.25%105K | -97.20%3K | -81.20%22K | -46.45%400K | -46.62%79K | -40.85%97K | -46.23%107K |
| Net investment income | -188.23%-3.54M | 305.12%4.01M | 179.81%2.1M | -64.13%2.76M | 9.07%-9.13M | 174.89%8.28M | -491.00%-1.96M | 66.44%-2.63M | 894.33%7.71M | -207.75%-10.04M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -122.13%-8.31M | 3,496.46%37.55M | -13,787.50%-4.38M | -1,268.83%-12.6M | 529,640.00%26.49M | 39,592.96%28.04M | -99.73%1.04M | -99.90%32K | -99.65%1.08M | -99.99%5K |
| Income from associates and other participating interests | 101.42%52K | -158.08%-3.66M | -103.75%-85K | -468.62%-1.65M | -18.74%1.43M | -230.79%-3.36M | 442.96%6.31M | 270.71%2.27M | -89.54%-290K | 1,497.62%1.76M |
| Special income (charges) | 86.62%-5.54M | -389.21%-41.39M | -41.39M | 0 | 0 | 0 | 14.31M | 0 | 99.34%-1.07M | 34K |
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---14.31M | --0 | --1.07M | ---34K |
| Less:Write off | -86.62%5.54M | --41.39M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | -160.44%-4.31M | 84.02%7.13M | 226.48%2.97M | -100.80%-10K | -82.08%167K | 409.68%4M | 257.38%3.87M | 671.19%910K | 261.45%1.25M | -14.57%932K |
| Income before tax | 24.92%-283.14M | 13.37%-377.09M | -69.20%-160.87M | 13.55%-128.31M | 44.76%-78.96M | 81.68%-8.96M | -184.11%-435.31M | -249.52%-95.08M | -181.73%-148.41M | -154.57%-142.95M |
| Income tax | 190.50%2.46M | -364.81%-2.72M | 2,062.67%1.47M | -14.76%306K | -1,009.38%-4.85M | 68.42%352K | -95.32%1.03M | -102.96%-75K | -98.11%359K | 160.00%533K |
| Net income | 23.71%-285.6M | 14.20%-374.38M | -70.88%-162.35M | 13.55%-128.61M | 48.35%-74.11M | 81.04%-9.31M | -188.03%-436.34M | -255.60%-95.01M | -191.48%-148.77M | -154.82%-143.48M |
| Net income continuous operations | 23.71%-285.6M | 14.20%-374.38M | -70.88%-162.35M | 13.55%-128.61M | 48.35%-74.11M | 81.04%-9.31M | -188.03%-436.34M | -255.60%-95.01M | -191.48%-148.77M | -154.82%-143.48M |
| Noncontrolling interests | 119.66%34.45M | 19.40%-175.23M | 42.76%-37.41M | 21.99%-40.3M | 32.58%-48.03M | -69.79%-49.5M | -384.40%-217.4M | -279.75%-65.35M | -202.24%-51.66M | -204.06%-71.24M |
| Net income attributable to the company | -60.71%-320.05M | 9.04%-199.14M | -321.31%-124.93M | 9.06%-88.31M | 63.89%-26.09M | 301.62%40.19M | -152.23%-218.94M | -137.89%-29.65M | -186.63%-97.11M | -137.38%-72.24M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -60.71%-320.05M | 9.04%-199.14M | -321.31%-124.93M | 9.06%-88.31M | 63.89%-26.09M | 301.62%40.19M | -152.23%-218.94M | -137.89%-29.65M | -186.63%-97.11M | -137.38%-72.24M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -60.51%-8.78 | 8.99%-5.47 | -324.69%-3.44 | 9.74%-2.41 | 63.82%-0.72 | 303.70%1.1 | -151.02%-6.01 | -138.03%-0.81 | -185.58%-2.67 | -136.05%-1.99 |
| Diluted earnings per share | -60.51%-8.78 | 8.99%-5.47 | -322.24%-3.44 | 9.13%-2.4263 | 63.82%-0.72 | 303.70%1.1 | -151.90%-6.01 | -138.61%-0.8147 | -189.30%-2.67 | -136.38%-1.99 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |